back to top
HomeMarketHON Earnings: Highlights of Honeywell’s Q3 2024 report | AlphaStreet

HON Earnings: Highlights of Honeywell’s Q3 2024 report | AlphaStreet

-

Engineering firm Honeywell Worldwide Inc. (NASDAQ: HON) Thursday reported a rise in adjusted earnings and gross sales for the third quarter of 2024.

At $9.7 billion, whole gross sales have been up 6% year-over-year within the September quarter. Gross sales on the core Aerospace Applied sciences section grew 12%, driving the top-line development.

On an adjusted foundation, third-quarter earnings elevated 8% yearly to $2.58 per share. In the meantime, unadjusted revenue decreased to $1.41 billion or $2.16 per share in Q3 from $1.51 billion or $2.27 per share in the identical interval of 2023.

Vimal Kapur, CEO of Honeywell, mentioned, Honeywell executed through a challenging environment in the third quarter, delivering segment margin and adjusted earnings per share above the high end of our guidance.”

Prior Efficiency

LEAVE A REPLY

Please enter your comment!
Please enter your name here

CAPTCHA


LATEST POSTS

Ecosystem Drive Ledger Revolutionizes Knowledge Administration for New Power Automobiles – Blockchain Information Website

As the worldwide new vitality car (NEV) market grows quickly, knowledge administration has change into a key driver of innovation and optimization within the {industry}....

Azerbaijan’s Ministry of {Digital} Improvement and Transport introduced occasions it should set up inside COP29 – Blockchain Information Website

The Ministry of {Digital} Improvement and Transport of the Republic of Azerbaijan (MDDT) has introduced the occasions it should set up inside the framework of...

PlanB's Bitcoin Value Roadmap To $1,000,000 Begins Enjoying Out, Right here's The Relaxation Of The Prediction | Bitcoinist.com

The crypto business has been riddled with intense exercise prior to now few weeks, coinciding with a run earlier than and after the US elections....

Aytu BioScience inventory hits 52-week low at $1.8 amid market challenges By Investing.com

In a difficult market atmosphere, Aytu BioScience Inc . (NASDAQ:) inventory has touched a 52-week low, reaching a worth stage of $1.8. This downturn...

Most Popular